428 related articles for article (PubMed ID: 16927022)
1. Influence of chk1 and plk1 silencing on radiation- or cisplatin-induced cytotoxicity in human malignant cells.
Gao Q; Huang X; Tang D; Cao Y; Chen G; Lu Y; Zhuang L; Wang S; Xu G; Zhou J; Ma D
Apoptosis; 2006 Oct; 11(10):1789-800. PubMed ID: 16927022
[TBL] [Abstract][Full Text] [Related]
2. Mitotic DNA damage response: Polo-like kinase-1 is dephosphorylated through ATM-Chk1 pathway.
Lee HJ; Hwang HI; Jang YJ
Cell Cycle; 2010 Jun; 9(12):2389-98. PubMed ID: 20581453
[TBL] [Abstract][Full Text] [Related]
3. [Silencing of cell cycle checkpoint kinase gene enhances cisplatin-induced apoptosis of lung cancer cells].
Ye F; Xie DX; Lu YP; Gao QL
Zhonghua Zhong Liu Za Zhi; 2009 Nov; 31(11):804-9. PubMed ID: 20137342
[TBL] [Abstract][Full Text] [Related]
4. [Down-regulation of Chk1/Chk2 gene expression increases apoptosis in irradiated HeLa cells and its mechanism].
Gao QL; Ye F; Xing H; Xie DX; Lu YP; Zhou JF; Ma D
Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):178-82. PubMed ID: 19615254
[TBL] [Abstract][Full Text] [Related]
5. PLK1 is a critical determinant of tumor cell sensitivity to CPT11 and its inhibition enhances the drug antitumor efficacy in squamous cell carcinoma models sensitive and resistant to camptothecins.
Zuco V; De Cesare M; Zaffaroni N; Lanzi C; Cassinelli G
Oncotarget; 2015 Apr; 6(11):8736-49. PubMed ID: 25826089
[TBL] [Abstract][Full Text] [Related]
6. Novel oncolytic adenovirus selectively targets tumor-associated polo-like kinase 1 and tumor cell viability.
Zhou J; Gao Q; Chen G; Huang X; Lu Y; Li K; Xie D; Zhuang L; Deng J; Ma D
Clin Cancer Res; 2005 Dec; 11(23):8431-40. PubMed ID: 16322306
[TBL] [Abstract][Full Text] [Related]
7. The role of Polo-like kinase 1 in the inhibition of centrosome separation after ionizing radiation.
Zhang W; Fletcher L; Muschel RJ
J Biol Chem; 2005 Dec; 280(52):42994-9. PubMed ID: 16157594
[TBL] [Abstract][Full Text] [Related]
8. Ectopic expression of Plk1 leads to activation of the spindle checkpoint.
Tang J; Erikson RL; Liu X
Cell Cycle; 2006 Nov; 5(21):2484-8. PubMed ID: 17102638
[TBL] [Abstract][Full Text] [Related]
9. Adaptation to the ionizing radiation-induced G2 checkpoint occurs in human cells and depends on checkpoint kinase 1 and Polo-like kinase 1 kinases.
Syljuåsen RG; Jensen S; Bartek J; Lukas J
Cancer Res; 2006 Nov; 66(21):10253-7. PubMed ID: 17079442
[TBL] [Abstract][Full Text] [Related]
10. A PIM-CHK1 signaling pathway regulates PLK1 phosphorylation and function during mitosis.
Adam K; Cartel M; Lambert M; David L; Yuan L; Besson A; Mayeux P; Manenti S; Didier C
J Cell Sci; 2018 Aug; 131(15):. PubMed ID: 29976560
[TBL] [Abstract][Full Text] [Related]
11. Impact of iASPP on chemoresistance through PLK1 and autophagy in ovarian clear cell carcinoma.
Chan KK; Wong OG; Wong ES; Chan KK; Ip PP; Tse KY; Cheung AN
Int J Cancer; 2018 Sep; 143(6):1456-1469. PubMed ID: 29663364
[TBL] [Abstract][Full Text] [Related]
12. Polo-like kinase1 (Plk1) knockdown enhances cisplatin chemosensitivity via up-regulation of p73α in p53 mutant human epidermoid squamous carcinoma cells.
Tyagi S; Bhui K; Singh R; Singh M; Raisuddin S; Shukla Y
Biochem Pharmacol; 2010 Nov; 80(9):1326-34. PubMed ID: 20655883
[TBL] [Abstract][Full Text] [Related]
13. A novel mechanism of checkpoint abrogation conferred by Chk1 downregulation.
Xiao Z; Xue J; Sowin TJ; Rosenberg SH; Zhang H
Oncogene; 2005 Feb; 24(8):1403-11. PubMed ID: 15608676
[TBL] [Abstract][Full Text] [Related]
14. PLK1 blockade enhances therapeutic effects of radiation by inducing cell cycle arrest at the mitotic phase.
Inoue M; Yoshimura M; Kobayashi M; Morinibu A; Itasaka S; Hiraoka M; Harada H
Sci Rep; 2015 Oct; 5():15666. PubMed ID: 26503893
[TBL] [Abstract][Full Text] [Related]
15. Co-abrogation of Chk1 and Chk2 by potent oncolytic adenovirus potentiates the antitumor efficacy of cisplatin or irradiation.
Ye F; Yang Z; Liu Y; Gong D; Ji T; Wang J; Xi B; Zhou J; Ma D; Gao Q
Cancer Gene Ther; 2014 May; 21(5):209-17. PubMed ID: 24853623
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of Polo-like kinase 1 elevates drug sensitivity of breast cancer cells in vitro and in vivo.
Spänkuch B; Heim S; Kurunci-Csacsko E; Lindenau C; Yuan J; Kaufmann M; Strebhardt K
Cancer Res; 2006 Jun; 66(11):5836-46. PubMed ID: 16740723
[TBL] [Abstract][Full Text] [Related]
17. Chk1 instability is coupled to mitotic cell death of p53-deficient cells in response to virus-induced DNA damage signaling.
Jurvansuu J; Fragkos M; Ingemarsdotter C; Beard P
J Mol Biol; 2007 Sep; 372(2):397-406. PubMed ID: 17663993
[TBL] [Abstract][Full Text] [Related]
18. Polo-like kinase 1 inactivation following mitotic DNA damaging treatments is independent of ataxia telangiectasia mutated kinase.
Yuan JH; Feng Y; Fisher RH; Maloid S; Longo DL; Ferris DK
Mol Cancer Res; 2004 Jul; 2(7):417-26. PubMed ID: 15280449
[TBL] [Abstract][Full Text] [Related]
19. Checkpoint kinase 1 (Chk1) is required for mitotic progression through negative regulation of polo-like kinase 1 (Plk1).
Tang J; Erikson RL; Liu X
Proc Natl Acad Sci U S A; 2006 Aug; 103(32):11964-9. PubMed ID: 16873548
[TBL] [Abstract][Full Text] [Related]
20. Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase-activated protein kinase 2 in mediating DNA damage-induced cell cycle arrest: implications for cancer therapy.
Xiao Z; Xue J; Sowin TJ; Zhang H
Mol Cancer Ther; 2006 Aug; 5(8):1935-43. PubMed ID: 16928813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
